VIRO.CO
Price:
$15.45
Market Cap:
$119.51M
ViroGates A/S develops and markets prognostic products for the healthcare sector. It offers suPARnostic, a blood test that measures the soluble urokinase plasminogen activator receptor (suPAR) protein in the bloodstream used for emergency departments in hospitals to improve clinical decisions on hospitalization or discharge of acute medical patients and reduce healthcare cost. The company also provides suPARnostic TurbiLatex, a latex particle-enhanced turbidimetric immunoassay that quantitatively determines the suPAR level in human K2-EDTA- or lithium heparin plasma samples; suPARnostic Quick Triage kit, which is used in the point of care situation for early warning and patient triaging; and...[Read more]
Industry
Medical - Devices
IPO Date
2018-06-26
Stock Exchange
CPH
Ticker
VIRO.CO
According to ViroGates A/S’s latest financial reports and current stock price. The company's current PE Ratio is -9.42. This represents a change of 110.26% compared to the average of -4.48 of the last 4 quarters.
The mean historical PE Ratio of ViroGates A/S over the last ten years is -23.18. The current -9.42 PE Ratio has changed 3.96% with respect to the historical average. Over the past ten years (40 quarters), VIRO.CO's PE Ratio was at its highest in in the June 2024 quarter at -2.75. The PE Ratio was at its lowest in in the March 2017 quarter at -60.07.
Average
-23.18
Median
-17.47
Minimum
-60.28
Maximum
-1.83
Discovering the peaks and valleys of ViroGates A/S PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 169.71%
Maximum Annual PE Ratio = -1.83
Minimum Annual Increase = -89.60%
Minimum Annual PE Ratio = -60.28
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -4.92 | 169.71% |
| 2023 | -1.83 | -89.60% |
| 2022 | -17.55 | -47.36% |
| 2021 | -33.34 | 91.74% |
| 2020 | -17.39 | 142.33% |
| 2019 | -7.17 | -42.05% |
| 2018 | -12.38 | -60.77% |
| 2017 | -31.56 | -30.50% |
| 2016 | -45.41 | -24.67% |
The current PE Ratio of ViroGates A/S (VIRO.CO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-8.10
5-year avg
-15.00
10-year avg
-23.18
ViroGates A/S’s PE Ratio is less than Scandinavian Medical Solutions A/S (37.38), less than Pharma Equity Group A/S (-6.11), less than Stenocare A/S (-2.14), less than Monsenso A/S (-1.93), less than Brain+ A/S (-0.35),
| Company | PE Ratio | Market cap |
|---|---|---|
| 37.38 | $105.49M | |
| -6.11 | $126.44M | |
| -2.14 | $62.19M | |
| -1.93 | $12.75M | |
| -0.35 | $11.10M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ViroGates A/S using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ViroGates A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is ViroGates A/S's PE Ratio?
How is the PE Ratio calculated for ViroGates A/S (VIRO.CO)?
What is the highest PE Ratio for ViroGates A/S (VIRO.CO)?
What is the 3-year average PE Ratio for ViroGates A/S (VIRO.CO)?
What is the 5-year average PE Ratio for ViroGates A/S (VIRO.CO)?
How does the current PE Ratio for ViroGates A/S (VIRO.CO) compare to its historical average?